Role Of Shubhdeep Liv-Gud Pill In Fatty Liver (Yakrutdalyodara)
Phase 4
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2020/02/023410
- Lead Sponsor
- Shubhdeep Ayurveda Medical College And Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patient presenting with clinical feature of yakrutdalyodara(Fatty liver).
2. Patient with or without the clinical feature of yakrutdalyodara, diagnosed to be having USG whole abdomen where include for the study.
3. Patient age between 20-60 years with either sex.
4. Patient of alcoholic addiction, obesity, type-2 diabetes mellitus.
Exclusion Criteria
1. Patient aged less than 20 yr and more than 60 years.
2. Patient with hepatic encephalopathy, systemic multiorgan syndrom, malignency of liver and cirrhosis of liver and prehepatic and hepatic coma, bleeding disorder, etc.
3. Pregnent women.
4. Hepatitis B and C.
5. Patient on steroid treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Improve power of digestion. <br/ ><br>2) Relief in anorexia. <br/ ><br>3) Relief in indigestion. <br/ ><br>4) Relief in weakness. <br/ ><br>5) Relief in fever. <br/ ><br>6) Relief in constipation.Timepoint: 45th day.
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI